Keratin-18: Diagnostic, Prognostic, and Theragnostic for Alcohol-Associated Hepatitis
- PMID: 33306505
- PMCID: PMC7775325
- DOI: 10.14309/ajg.0000000000001042
Keratin-18: Diagnostic, Prognostic, and Theragnostic for Alcohol-Associated Hepatitis
Abstract
It is still sometimes difficult to differentiate alcohol-associated hepatitis (AH) from other liver problems. In this edition of AJG, Atkinson et al. showed that keratin-18 (intermediate filament protein) is a promising biomarker for predicting histological severity of AH, defining the type of hepatocyte death (necrosis vs apoptosis), predicting 90-day mortality, and predicting the response to corticosteroid therapy in severe AH. The authors conclude that K18 is diagnostic, prognostic, and may be a theragnostic marker for prednisolone therapy and note that "serum K18 estimation should be adopted into routine clinical practice." We agree.
Copyright © 2020 by The American College of Gastroenterology.
Figures
Comment on
-
In Severe Alcoholic Hepatitis, Serum Keratin-18 Fragments Are Diagnostic, Prognostic, and Theragnostic Biomarkers.Am J Gastroenterol. 2020 Nov;115(11):1857-1868. doi: 10.14309/ajg.0000000000000912. Am J Gastroenterol. 2020. PMID: 33156105
References
-
- Atkinson SR, Grove JI, Liebig S, Astbury S, Vergis N, Goldin R, Quaglia A, Bantel H, Guha IN, Thursz MR, Newcombe P, Strnad P, Aithal GP. In severe alcoholic hepatitis, serum keratin-18 fragments are diagnostic, prognostic and theragnostic biomarkers. Amer J Gastroenterol (in press). - PubMed
-
- Crabb DW, Bataller R, Chalasani NP, Kamath PS, Lucey M, Mathurin P, McClain C, McCullough A, Mitchell MC, Morgan TR, Nagy L, Radaeva S, Sanyal A, Shah V, Szabo G, Consortia NAH. Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia. Gastroenterology 2016; 150(4):785–90. doi: 10.1053/j.gastro.2016.02.042. PubMed PMID: 26921783. - DOI - PMC - PubMed
-
- Forrest EH, Atkinson SR, Richardson P, et al. Application of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitis. J Hepatol 2018; 68(3):511–518. doi: 10.1016/j.jhep.2017.11.017. Epub 2017 Nov 21. PubMed PMID: 29175535. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
